Cardiac: Page 2

  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic leads $100M investment in Pulnovo Medical

    Medtronic formed a commercial agreement with Pulnovo alongside its investment.

    By • April 21, 2026
  • The CathWorks FFRangio System on a cart.
    Image attribution tooltip
    Permission granted by CathWorks
    Image attribution tooltip

    Medtronic closes $585M purchase of CathWorks

    The deal is the second tuck-in acquisition this year for Medtronic, which has signaled its intent to pursue more M&A in its core business lines.

    By • April 20, 2026
  • Intuitive Surgical's da Vinci 5 robotic system. Explore the Trendline➔
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Trendline

    Robotic surgery's innovation boom

    Surgical robotics is one of the most exciting spaces in the medical device industry, with companies developing new systems and battling for market share.

    By MedTech Dive staff
  • A modern industrial building with beige and white walls and large blue-tinted glass windows. The name “Stryker” is mounted in black letters on the upper portion of the building. A white smokestack protrudes from the roof, and the sky is light and partly cloudy.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Stryker to buy Amplitude Vascular Systems

    Amplitude’s intravascular lithotripsy technology could emerge as a challenger to Shockwave IVL, Leerink Partners analyst Mike Kratky wrote.

    By • April 13, 2026
  • Pulse Biosciences' pulsed field ablation tool is displayed against a white background.
    Image attribution tooltip
    Permission granted by Pulse Biosciences
    Image attribution tooltip

    Pulse Biosciences hires Liane Teplitsky as COO

    The appointment gives a former Abbott leader oversight of efforts to bring a pulsed field ablation device to market.

    By • April 10, 2026
  • A picture of a blue pulsed field ablation catheter against a gray background.
    Image attribution tooltip
    Courtesy of Johnson & Johnson MedTech
    Image attribution tooltip

    J&J launches enhanced PFA device in Europe

    The Varipulse Pro pulsed field ablation platform, which has received a CE mark, will be a focus at the upcoming European Heart Rhythm Association annual meeting in Paris.

    By • April 7, 2026
  • Johnson & Johnson's Impella CP heart pump is shown in an illustration of the heart.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s Impella heart pump shows no patient benefit in 2 trials

    Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat heart attack patients who don’t have cardiogenic shock.

    By • April 1, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins CE mark for OmniaSecure defibrillation lead

    The device maker designed the lead to have the safety benefits of small-diameter devices without sacrificing durability.

    By • March 31, 2026
  • Medtronic's Symplicity Spyral device is shown against a white background.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic to study renal denervation combined with PCI

    Medtronic detailed plans to further study the blood pressure treatment while releasing additional data from the SPYRAL HTN trials that showed the procedure reduced hypertensive emergencies.

    By • March 31, 2026
  • A rendering of a rounded device with a wire structure surrounded by mesh.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific posts positive stroke prevention data for Watchman

    The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and efficacy goals in the closely watched CHAMPION-AF study.

    By • March 30, 2026
  • A physician in blue scrubs and a mask looks at Philips' DeviceGuide images on a large screen.
    Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    Philips wins FDA clearance for imaging device developed with Edwards

    The system uses AI to optimize the placement of Edwards’ mitral valve repair device.

    By • March 27, 2026
  • Silhouette of stressed businesswoman in the office.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Endologix to close production facility, lay off 31 people

    The company acquired the facility in the PQ Bypass takeover it struck in the aftermath of its bankruptcy filing.

    By • March 26, 2026
  • An aerial view of four clinicians and Distalmotion's Dexter surgical robot.
    Image attribution tooltip
    Permission granted by Distalmotion
    Image attribution tooltip

    Meet 8 medtech companies redefining surgical robotics

    Executives at companies innovating new robotic surgery platforms shared their progress and challenges with MedTech Dive. Read our series of stories on the next generation of surgical robot developers.

    By • Updated June 22, 2026
  • An illustration of the Medtronic OmniaSecure defibrillation lead in the heart.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication

    The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate the natural electrical system.

    By • March 25, 2026
  • Thermo Fisher Scientific
    Image attribution tooltip
    Courtesy of Thermo Fisher Scientific
    Image attribution tooltip

    Thermo Fisher completes $8.9B buyout of Clario

    Thermo Fisher plans to create a fast-growing business by integrating Clario’s data capture and management system with its existing capabilities.

    By • March 25, 2026
  • A closeup of JenaValve's Trilogy transcatheter valve to treat aortic regurgitation.
    Image attribution tooltip
    Permission granted by JenaValve
    Image attribution tooltip

    JenaValve snags FDA approval in aortic regurgitation

    The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition from the Federal Trade Commission.

    By • March 18, 2026
  • Field Medical's FieldForce pulsed field ablation system for ventricular tachycardia is displayed.
    Image attribution tooltip
    Courtesy of Field Medical
    Image attribution tooltip

    PFA startup Field Medical appoints Mark Turco as CEO

    Turco, an interventional cardiologist, has held roles including CEO of JC Medical and chief medical officer of Medtronic’s aortic and peripheral vascular business.

    By • March 18, 2026
  • The SS Innovations SSi Mantra robotic system.
    Image attribution tooltip
    Permission granted by SS Innovations
    Image attribution tooltip

    SS Innovations raises $18.6M as surgical robot nears US market

    Intuitive co-founder Fred Moll invested $2 million, supporting SS Innovations’ efforts to launch its robot in the U.S.

    By • March 10, 2026
  • Boston Scientific's Farapulse pulsed field ablation system is shown in an operating room.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific gets Farapulse label expansion in Europe

    With CE mark approval, the pulsed field ablation procedure becomes available to treat patients in Europe with persistent atrial fibrillation.

    By • March 3, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott wins FDA approval for updated heart failure monitoring device

    The company redesigned the reader to fit in a carry-on suitcase and be easier to use day to day.

    By • March 2, 2026
  • A modern architectural design building featuring a red-brick façade with large glass windows displays a prominent sign of the Food and Drug Administration.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    FDA posts early alert for safety issue with Impella heart pump devices

    The cassettes have an increased risk of purge leaks that can lead to the loss of hemodynamic support.

    By • Feb. 26, 2026
  • A lab technician runs Guardant Health's Shield blood test for colorectal cancer screening in a lab.
    Image attribution tooltip
    Courtesy of Business Wire
    Image attribution tooltip

    Guardant buys MetaSight for $59M upfront to acquire blood test tech

    MetaSight uses metabolomics, lipidomics and proteomics mass spectrometry technologies to develop tests for specific diseases, including conditions outside of oncology.

    By • Feb. 23, 2026
  • A phone screen says "possible hypertension", and a watch next to the phone displays the same message.
    Image attribution tooltip
    Courtesy of Apple
    Image attribution tooltip

    Apple Watch’s hypertension feature may miss some cases, researchers find

    The absence of an alert provides limited reassurance, particularly for older adults or people with an elevated risk of high blood pressure, according to the study’s authors. 

    By • Feb. 19, 2026
  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards focuses on earlier TAVR adoption

    The heart valve specialist reported a second straight quarter of double-digit TAVR sales growth and credited recent study results with driving a “sense of urgency” for treating patients.

    By • Feb. 11, 2026
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    4 takeaways from the 2026 AF Symposium

    Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation treatments, including pulsed field ablation catheters.

    By • Feb. 10, 2026
  • A picture of a medical catheter against a white background.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine

    Abbott and Pulse released their findings at the AF Symposium that wrapped this weekend in Boston.

    By • Feb. 9, 2026